IGF1 and prostate neoplasm: Given that current ADT can systematically affect AR signaling in both AR-expressing tumor cells and surrounding stromal cells, our data implicate an underlying mechanism for IGF1 signaling forgoing the reliance on AR-mediated regulation in prostate tumor cells to induce hormone refractoriness and CRPC development.